Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practical aspects of discovery pathology.

John E Burkhardt1, Anne M Ryan, Paul-Georg Germann

  • 1Department of Drug Safety Evaluation, Pfizer Global Research and Development, Groton, CT 06340, USA. John_E_Burkhardt@groton.pfizer.com

Toxicologic Pathology
|March 14, 2002
PubMed
Summary

Pathologists can accelerate drug discovery by creating disease models and analyzing treatment responses and toxicity. Their expertise improves research decisions, leading to faster development and better drug candidate survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age- and sex-related changes in body weights and clinical pathology analytes in cynomolgus monkeys (Macaca Fascicularis) of Mauritius origin.

Veterinary clinical pathology·2022
Same author

Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.

The Journal of toxicological sciences·2021
Same author

Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.

Lab on a chip·2019
Same author

Medical-Legal Partnerships to Enhance Residency Training in Advance Care Planning.

Family medicine·2019
Same author

Kidney Pathology and Investigative Nephrotoxicology Strategies Across Species.

Seminars in nephrology·2019
Same author

Medical Interpreters in Outpatient Practice.

Annals of family medicine·2018

Area of Science:

  • Pathology
  • Drug Discovery and Development

Background:

  • Pathologists possess unique expertise valuable for pharmaceutical research.
  • Traditional roles may not fully leverage pathologist capabilities in drug development.

Purpose of the Study:

  • To outline the expanded role of pathologists in drug discovery and development.
  • To demonstrate the tangible benefits of integrating pathologists into pharmaceutical research programs.

Main Methods:

  • Establishing and utilizing disease models for therapy assessment.
  • Characterizing disease modifications in response to therapeutic interventions.
  • Evaluating toxicologic mechanisms and responses to drug candidates.
  • Facilitating multidisciplinary monitoring of adverse events.

Related Experiment Videos

Main Results:

  • Pathologists can enhance the assessment of potential therapies.
  • Characterization of disease and drug responses provides critical data.
  • Toxicologic evaluations inform candidate selection and safety.
  • Monitoring adverse events aids in clinical trial management.

Conclusions:

  • Integrating pathologists into drug discovery offers significant advantages.
  • Pathologist involvement can lead to time savings and improved research decisions.
  • Leveraging pathologist expertise can accelerate programs and improve drug candidate survival.